Skip to main content
SLAS2024 Main banner
Sartorius Ad
Back

Richard I. Robinson, PhD (he/him/his)

Novartis Biomedical Research, Massachusetts, United States

Richard I. Robinson, Ph.D.
Associate Director
Novartis Biomedical Research

Richard Robinson is a Synthetic-Medicinal Chemist with over 20 years industry experience in the discovery and advancement of new therapeutics. His primary focus is in the application of Synthetic Technologies and Automation towards drug discovery, leading to multiple collaborations with academic partners across Europe and the US. Through the Genesis Labs at Novartis, Richard has contributed to the founding and implementation of two technology platform "startups" established at Novartis, using Automation and Flow Technology approaches.

Richard has successfully contributed to over 80 projects across his career, tackling a broad range of disease areas (Respiratory, Cardiovascular and Oncology) and novel modalities across the NBR pipeline. Through the Novartis Centre for Continuous Manufaturing and in collaboration with the Jensen group at MIT, he has published extensively at the interface of Chemistry and Engineering, showcasing real-world application of Self-Optimising Reactors, and Solid Handling Capabilities of CSTR's in Flow. As a active consortium partner within the MIT-Machine Learning for Pharmaceutical Discovery and Synthesis (MLPDS), he is helping pioneer and implement AI driven approaches in Synthesis Planning, Reaction and Property Prediction.

He earned a B.Sc. in Chemistry and Material Science (Hull), followed by a Ph.D in Chemistry from the University of Nottingham, UK.

Disclosure information not submitted.

Presentation(s):